-
Merck Raises Forecast as Sales of Its Cancer Immune Therapy Soar
25 Apr 2024 17:33 GMT
… of growth as Keytruda, an immune therapy for many types of cancer … Therapeutics Inc., which is testing immune therapy drugs for cancer.
The company …
-
Novel immunotherapy shows promise for high-risk sarcomas: HEROS 2.0 trial results published
25 Apr 2024 06:27 GMT
… clinical trial of a novel immunotherapy for high-risk sarcomas in …
-
Tumor cells evade the immune system early on: Newly discovered mechanism could significantly improve cancer immunotherapies
24 Apr 2024 16:54 GMT
… rationales for new cancer immunotherapies and could make … rationales for new cancer immunotherapies and could make … render them inactive. Immunotherapies aim to overcome these … starting point for significantly improving immunotherapies,” says Jan Böttcher. …
-
GV20 Therapeutics Announces Publication in Cell Highlighting the Discovery of IGSF8 as an Innate Immune Checkpoint and Cancer Immunotherapy Target
24 Apr 2024 16:30 GMT
… innate immune checkpoint and cancer immunotherapy target" in the journal … evasion and resistance to cancer immunotherapy, whereas how tumors evade innate … -innate-immune-checkpoint-and-cancer-immunotherapy-target-302126064.html
SOURCE GV20 …
-
Post-surgery Immunotherapy boosts Kidney Cancer survival
24 Apr 2024 12:46 GMT
… reveals that administering pembrolizumab, an immunotherapy medication, to patients with clear …
-
Immunotherapy Combination Approved for Non-Muscle Invasive Bladder Cancer
24 Apr 2024 10:46 GMT
… Administration (FDA) has approved the immunotherapy-boosting drug N-803, which … used in combination with the immunotherapy Bacillus Calmette-Guerin (BCG) for … treatment with a bacteria-based immunotherapy called BCG, which is placed …
-
FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer after UCLA-led research shows improved outcomes for patients
24 Apr 2024 04:05 GMT
… Administration (FDA) has approved the immunotherapy-boosting drug N-803, which … used in combination with the immunotherapy Bacillus Calmette-Guerin (BCG) for … treatment with a bacteria-based immunotherapy called BCG, which is placed …
-
FDA Approves Immunotherapy That Can Spare Bladder Cancer Patients From Radical Surgery
23 Apr 2024 20:54 GMT
Immunotherapy is already a treatment option … . FDA approval of a novel immunotherapy gives bladder cancer patients an … (BCG), a standard of care immunotherapy for bladder cancer.
BCG is … to 40% of patients. Other immunotherapies used to treat NMIBC include …
-
Plasticity and Heterogeneity of CTLs: Impact on Cancer Immunotherapy
23 Apr 2024 20:50 GMT
… and plasticity: implications for cancer immunotherapy,” published in the March 2024 … optimize their therapeutic applications in immunotherapy.
This synthesis underscores the heterogeneity …
-
Health Canada authorizes Tecentriq SC (atezolizumab, solution for subcutaneous injection), the first cancer immunotherapy subcutaneous injection, for multiple cancer types
23 Apr 2024 17:54 GMT
… frequent travel to receive intravenous immune therapy," says Dr. Sara … , the time saved administering immunotherapy subcutaneously can improve workflow efficiency … a type of cancer immunotherapy treatment. Immunotherapy treatments work by helping …